0001840655-21-000001.txt : 20210223 0001840655-21-000001.hdr.sgml : 20210223 20210223125615 ACCESSION NUMBER: 0001840655-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210223 DATE AS OF CHANGE: 20210223 EFFECTIVENESS DATE: 20210223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NephroDI Therapeutics, Inc. CENTRAL INDEX KEY: 0001840655 IRS NUMBER: 822363611 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-390191 FILM NUMBER: 21664151 BUSINESS ADDRESS: STREET 1: 1606 CHESTNUT STREET, UNIT 3 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 206-696-0546 MAIL ADDRESS: STREET 1: 1606 CHESTNUT STREET, UNIT 3 CITY: PHILADELPHIA STATE: PA ZIP: 19103 D 1 primary_doc.xml X0708 D LIVE 0001840655 NephroDI Therapeutics, Inc. 1606 CHESTNUT STREET, UNIT 3 PHILADELPHIA PA PENNSYLVANIA 19103 206-696-0546 DELAWARE None None Corporation true 2017 Rachael Hagan 1606 Chestnut Street, Unit 3 Philadelphia PA PENNSYLVANIA 19103 Executive Officer Director Jeff M. Sands, M.D. 1606 Chestnut Street, Unit 3 Philadelphia PA PENNSYLVANIA 19103 Executive Officer Donna See 1606 Chestnut Street, Unit 3 Philadelphia PA PENNSYLVANIA 19103 Director Chris Garabedian 1606 Chestnut Street, Unit 3 Philadelphia PA PENNSYLVANIA 19103 Director Fred Callori 1606 Chestnut Street, Unit 3 Philadelphia PA PENNSYLVANIA 19103 Director Pharmaceuticals Decline to Disclose 06b false 2021-02-11 false true false 0 1600018 1600018 0 false 1 0 0 0 false NephroDI Therapeutics, Inc. Rachael Hagan Rachael Hagan President 2021-02-23